Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $1.06M | $0.17 |
| 2024 | $0.00 | $2.55M | $0.28 |
| 2023 | $0.00 | $171.4K | $0.02 |
Social Signal Score
Valuation
Project earnings forward and see what return today's price implies.
Seeded from AFJK's reported EPS growth of 199.1% a year over 2 years. Historical EPS growth of 199% reflects a recovery from a low base and won't persist. Capped at 30% as a starting point.
- EPS in 5 years
- $0.97
- Implied price
- $17.50
- Return from $12.20
- 7.5% a year
To earn 15.0% a year on these assumptions you'd need to buy at $8.70 — -28.7% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| 20.0% | -8.5% | -4.3% | -0.8% | 2.3% | 5.1% |
| 25.0% | -4.7% | -0.4% | 3.3% | 6.6% | 9.5% |
| 30.0% | -0.9% | 3.6% | 7.5% | 10.8% | 13.8% |
| 35.0% | 2.9% | 7.6% | 11.6% | 15.1% | 18.2% |
| 40.0% | 6.7% | 11.6% | 15.7% | 19.4% | 22.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (1)
- Newsdefenseworld.net·3d ago·Neutral
Aimei Health Technology (NASDAQ:AFJK) Shares Up 0.4% – Here’s What Happened Aimei Health Technology Co., Ltd. (NASDAQ: AFJK - Get Free Report)'s share price rose 0.4% during trading on Tuesday. The company traded as high as $12.14 and last traded at $12.01. Approximately 84,299 shares were traded during trading, an increase of 194% from the average session volume of 28,719 shares. The stock had previously closed
View source ↗